Novo Nordisk A/S | NOVOB - Pre Tax Profit

Stock Price
236.10
Daily Change
-4.00 -1.67%
Monthly
-4.39%
Yearly
-42.35%
Q2 Forecast
224.75

Novo Nordisk reported DKK33.8B in Pre-Tax Profit for its fiscal quarter ending in June of 2025.





Pre Tax Profit Change Date
Bausch Health Companies USD 218M 78M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Merck USD 6.74B 22M Sep/2025
Novartis USD 4.64B 445M Dec/2025
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Novo Nordisk DKK 25.52B 8.29B Sep/2025
Pacira USD 9.52M 11.45M Sep/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Supernus Pharmaceuticals USD -1.91M 56.04M Dec/2025